IQInvest
Sign in

BSX

Boston Scientific Corporation

NYQ · Healthcare

$49.71

$0.70 (+1.43%)up 1.43%

25 August 2026 · delayed 15+ min

F

Quality score58.1 / 100

Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.

Boston Scientific Corporation earns a F on good profit margins (>10%) and positive free cash flow but high debt-to-equity ratio (>2.0) and price well below 200-day SMA (downtrend). Consider alternatives with better risk/reward profiles.

Model stance WEAK HOLD Suggested position 4.0% · $400.00 IQInvest estimate
Adjusted for Moderate investors, Medium-term investors 4.0% suggested allocation Change these

These change the suggested position size and the stance, not the category scores. Amount is in dollars.

IQ-BSX-20260825engine v1 · 7-category weighted scorecard

What it is worth, depending who you ask.

Today’s price against the year it has had and the targets analysts publish. Every marker is a reported figure, not a projection of ours.

52-week low

$42.20

Lowest analyst target

$44.00

Today's price

$49.71

Mean analyst target

$62.69

Highest analyst target

$94.00

52-week high

$109.50

BSX trades 11% of the way up its 52-week range, between $42.20 and $109.50. The mean analyst target of $62.69 is 26.1% above today's price.

Today’s price 52-week range Analyst price targets

Scored categories

Financial healthGood profit margins (>10%); Positive free cash flow; High debt-to-equity ratio (>2.0) 80.023%

Profit margin

17.50%

Net profit per unit of revenue

healthyWhat this means

Of every 100 units of revenue, this much survives as profit.

A comfortable buffer between revenue and costs.

Operating margin

22.90%

Before interest and tax

healthyWhat this means

Profit from operations, before interest and tax, per 100 of revenue.

The operations themselves are comfortably profitable.

Gross margin

69.19%

After the cost of goods only

highWhat this means

What is left of revenue after only the direct cost of the product.

Little marginal cost per sale, which is what lets software and pharma fund heavy R&D.

Return on equity

15.34%

Profit per unit of shareholder capital

strongWhat this means

Profit generated per unit of shareholder capital.

Above 15% is generally considered a good business.

Return on assets

6.19%

Profit per unit of assets

strongWhat this means

Profit generated per unit of everything the company owns.

The assets are working hard.

Debt to equity

50.15

Borrowings against equity

moderateWhat this means

Borrowings measured against shareholder capital.

Normal for most established companies.

Current ratio

1.24

Short-term assets over short-term debts

adequateWhat this means

Short-term assets against short-term obligations.

Enough to cover near-term bills.

Quick ratio

0.56

As above, excluding inventory

adequateWhat this means

Short-term assets excluding inventory, against short-term debts.

Near-term obligations are roughly covered without selling inventory.

Revenue growth

7.50%

Year on year

growingWhat this means

Change in revenue against the same period last year.

A healthy expansion rate.

Earnings growth

15.10%

Year on year

strongWhat this means

Change in earnings against the same period last year.

Profit is compounding at a good clip.

Revenue

$10.65B

Trailing twelve months

Free cash flow

$2.45B

Cash left after capital spending

Operating cash flow

$4.53B

Cash from the business itself

Payout ratio

0.00%

Dividends as a share of earnings

noneWhat this means

The share of earnings paid out as dividends.

All earnings are retained in the business.

Growth & momentumPoor 1-year return (-52.7%); Low Sharpe ratio (0.14) 0.022%

Return, 1 month

7.92%

Return, 3 months

-1.49%

Return, 6 months

-32.35%

Return, year to date

-47.51%

Return, 1 year

-52.71%

Return, 3 years

-1.41%

Sharpe ratio

0.14

Return earned per unit of risk

modestWhat this means

Return earned per unit of risk taken.

Below 1 is the common case; return did not strongly outpace the volatility.

Win rate

52.31%

Share of days that closed up

about evenWhat this means

The share of trading days that closed higher.

Close to a coin flip, which is the norm — returns come from the size of moves, not their count.

Average daily return

0.02%

Best day

8.99%

Worst day

-17.59%

ValuationAttractive PEG ratio (0.72) 90.018%

P/E ratio

20.13

Price against trailing earnings

moderateWhat this means

You pay 20.13 for every 1 unit of annual earnings.

Roughly the long-run market average band.

Forward P/E

14.48

Price against forecast earnings

lowWhat this means

Price against next year's *forecast* earnings.

The market expects little growth, or doubts the forecast.

PEG ratio

0.72

P/E adjusted for growth

cheap for the growthWhat this means

P/E divided by the growth rate — it asks whether the price is justified by the growth.

Under 1 is the classic Peter Lynch marker for growth you are not paying full price for.

Price to book

2.88

Price against balance-sheet equity

normalWhat this means

Price against the accounting value of the company's net assets.

A typical range for an established company.

Price to sales

3.43

Price against revenue

moderateWhat this means

Price against revenue — usable when a company has no profit yet.

A common range for a profitable, growing business.

EV / EBITDA

14.60

Whole-company value against cash earnings

moderateWhat this means

Whole-company value, debt included, against cash earnings.

A conventional range.

Enterprise value

$83.35B

Market value plus debt, minus cash — the price of the whole business

Shares outstanding

1,449,229,526

Shares the profit is split across

TechnicalRSI in healthy range (30-70); Price well below 200-day SMA (downtrend); MACD bearish (negative histogram) 70.015%

RSI (14)

53.5

Above 70 overbought, below 30 oversold

neutralWhat this means

A 0–100 momentum gauge over the last 14 sessions.

The middle band, where most trading days sit.

MACD

1.03

Momentum against its own trend

MACD histogram

-0.20

Positive is bullish

ADX

15.3

Trend strength; above 25 is a real trend

no clear trendWhat this means

Trend strength, regardless of direction.

Below about 20 the price is ranging rather than trending.

20-day average

$49.58

50-day average

$46.51

200-day average

$68.94

Price vs 50-day

6.88%

Price vs 200-day

-27.89%

Bollinger upper

$53.21

Bollinger lower

$45.95

Average true range

1.71

Typical daily trading range

Stochastic %K

26.3

RiskHigh drawdown risk 25.012%

Volatility, annualised

26.20%

How far it swings in a year

normalWhat this means

How far the price typically swings over a year.

A typical range for an individual share.

Beta

0.57

Moves against the wider market

steadier than the marketWhat this means

How much the price moves relative to the wider market.

Tends to move less than the index, in both directions.

Maximum drawdown

-60.58%

Worst peak-to-trough fall

severeWhat this means

The worst peak-to-trough fall in the period measured.

A fall this deep needs roughly a doubling to recover.

Risk category

High

The engine's own banding

Analyst viewAnalyst consensus: Buy; Significant upside potential (26.1%) 100.010%

Consensus

Buy

What covering analysts rate it

Analysts covering

29

Mean price target

$62.69

Highest target

$94.00

Lowest target

$44.00

Implied upside

26.11%

Target against today's price

largeWhat this means

How far the mean analyst target sits above today's price.

A wide gap, which as often means the price has fallen as that the target is right.

Price against the S&P 500

180 trading days to 2026-08-25

BSX is 49.0% down over the window, against 11.7% up for the S&P 500 — behind by 60.7 points.
BSX -49.0%S&P 500 +11.7%
Show the numbers
Sampled across the window. Both columns are rebased to 100 on 2025-12-05, so they can be compared directly.
DateCloseBSX rebasedS&P 500 rebased
2025-12-05$97.52100.0100.0
2025-12-29$95.7698.2100.5
2026-01-21$91.7194.0100.1
2026-02-11$73.4775.3101.0
2026-03-05$72.9974.899.4
2026-03-26$70.1772.094.3
2026-04-17$64.2365.9103.7
2026-05-08$53.9355.3107.7
2026-06-01$47.9849.2110.6
2026-06-23$45.6046.8107.2
2026-07-15$43.0444.1110.2
2026-08-05$47.7449.0112.4

How the score was built

Each category is scored 0–100, then multiplied by its weight. The seven contributions sum to the quality score.
CategoryScoreWeightContribution
Financial health80.023%18.4
Growth & momentum0.022%0.0
Valuation90.018%16.2
Technical70.015%10.5
Risk25.012%3.0
Analyst view100.010%10.0
ESG50.00%0.0
Quality score100%58.1

ESG is scored but carries no weight in this grade. Add ?esg=1 to the address to include it — the engine then redistributes weight across the other six, so the whole scorecard changes, not just one row.

Argue with the model

Every other grader hands you a number. This one hands you the model.

Move a slider, press Recalculate, and the grade is rebuilt from the same category scores. Nothing is hidden: the scores are the engine's, only the weighting is yours.

18%
23%
22%
12%
15%
10%
0%

These are IQInvest's own weights, totalling 100%.

Your grade

F

58.1 / 100

Identical to the IQInvest grade.

All 65 metricsOne flat sortable table, for when you want everything at once.
Metric Category Value Source
Shares outstandingValuation1,449,229,526Yahoo Finance
Price to salesValuation3.43Yahoo Finance
Price to bookValuation2.88Yahoo Finance
PEG ratioValuation0.72Yahoo Finance
P/E ratioValuation20.13Yahoo Finance
Forward P/EValuation14.48Yahoo Finance
EV / EBITDAValuation14.60Yahoo Finance
Enterprise valueValuation$83.35BYahoo Finance
Stochastic %KTechnical26.3Yahoo Finance
RSI (14)Technical53.5Yahoo Finance
Price vs 50-dayTechnical6.88%Yahoo Finance
Price vs 200-dayTechnical-27.89%Yahoo Finance
MACD histogramTechnical-0.20Yahoo Finance
MACDTechnical1.03Yahoo Finance
Bollinger upperTechnical$53.21Yahoo Finance
Bollinger lowerTechnical$45.95Yahoo Finance
Average true rangeTechnical1.71Yahoo Finance
ADXTechnical15.3Yahoo Finance
50-day averageTechnical$46.51Yahoo Finance
200-day averageTechnical$68.94Yahoo Finance
20-day averageTechnical$49.58Yahoo Finance
Volatility, annualisedRisk26.20%Yahoo Finance
Risk categoryRiskHighYahoo Finance
Maximum drawdownRisk-60.58%Yahoo Finance
BetaRisk0.57Yahoo Finance
VolumeMarket data5,990,207Yahoo Finance
Previous closeMarket data$49.01Yahoo Finance
OpenMarket data$48.79Yahoo Finance
EmployeesMarket data59,000Yahoo Finance
Day lowMarket data$48.54Yahoo Finance
Day highMarket data$49.99Yahoo Finance
Average volumeMarket data21,332,763Yahoo Finance
52-week lowMarket data$42.20Yahoo Finance
52-week highMarket data$109.50Yahoo Finance
Worst dayGrowth & momentum-17.59%Yahoo Finance
Win rateGrowth & momentum52.31%Yahoo Finance
Sharpe ratioGrowth & momentum0.14Yahoo Finance
Return, year to dateGrowth & momentum-47.51%Yahoo Finance
Return, 6 monthsGrowth & momentum-32.35%Yahoo Finance
Return, 3 yearsGrowth & momentum-1.41%Yahoo Finance
Return, 3 monthsGrowth & momentum-1.49%Yahoo Finance
Return, 1 yearGrowth & momentum-52.71%Yahoo Finance
Return, 1 monthGrowth & momentum7.92%Yahoo Finance
Best dayGrowth & momentum8.99%Yahoo Finance
Average daily returnGrowth & momentum0.02%Yahoo Finance
Revenue growthFinancial health7.50%Yahoo Finance
RevenueFinancial health$10.65BYahoo Finance
Return on equityFinancial health15.34%Yahoo Finance
Return on assetsFinancial health6.19%Yahoo Finance
Quick ratioFinancial health0.56Yahoo Finance
Profit marginFinancial health17.50%Yahoo Finance
Payout ratioFinancial health0.00%Yahoo Finance
Operating marginFinancial health22.90%Yahoo Finance
Operating cash flowFinancial health$4.53BYahoo Finance
Gross marginFinancial health69.19%Yahoo Finance
Free cash flowFinancial health$2.45BYahoo Finance
Earnings growthFinancial health15.10%Yahoo Finance
Debt to equityFinancial health50.15Yahoo Finance
Current ratioFinancial health1.24Yahoo Finance
Mean price targetAnalyst view$62.69Yahoo Finance
Lowest targetAnalyst view$44.00Yahoo Finance
Implied upsideAnalyst view26.11%Yahoo Finance
Highest targetAnalyst view$94.00Yahoo Finance
ConsensusAnalyst viewBuyYahoo Finance
Analysts coveringAnalyst view29Yahoo Finance
Add to portfolio Compare Peers Set a price target

Yahoo Finance via yfinance · delayed 15 minutes or more